Advertisement

Index by author

September 01, 2001; Volume 29,Issue 9

A

  1. Ackermann, Joseph M.

    1. The Use of 3-[2-(N,N-Diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a Specific CYP2D6 Probe in Human Liver Microsomes
      Nathalie Chauret, Barry Dobbs, Rebecca L. Lackman, Kevin Bateman, Deborah A. Nicoll-Griffith, David M. Stresser, Joseph M. Ackermann, Stephanie D. Turner, Vaughn P. Miller and Charles L. Crespi
      Drug Metabolism and Disposition September 2001, 29 (9) 1196-1200;

B

  1. Barecki, Mary E.

    1. In Vitro Characterization of the Inhibition Profile of Loratadine, Desloratadine, and 3-OH-Desloratadine for Five Human Cytochrome P-450 Enzymes
      Mary E. Barecki, Christopher N. Casciano, William W. Johnson and Robert P. Clement
      Drug Metabolism and Disposition September 2001, 29 (9) 1173-1175;

  2. Bateman, Kevin

    1. The Use of 3-[2-(N,N-Diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a Specific CYP2D6 Probe in Human Liver Microsomes
      Nathalie Chauret, Barry Dobbs, Rebecca L. Lackman, Kevin Bateman, Deborah A. Nicoll-Griffith, David M. Stresser, Joseph M. Ackermann, Stephanie D. Turner, Vaughn P. Miller and Charles L. Crespi
      Drug Metabolism and Disposition September 2001, 29 (9) 1196-1200;

  3. Benet, Leslie Z.

    1. Effect of α-Fluorination of Valproic Acid on Valproyl-S-Acyl-CoA Formation in Vivo in Rats
      Mark P. Grillo, Grazia Chiellini, Marco Tonelli and Leslie Z. Benet
      Drug Metabolism and Disposition September 2001, 29 (9) 1210-1215;

  4. Bi, Daoqin

    1. Metabolism of Vanoxerine, 1-[2-[bis(4-Fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl) Piperazine, by Human Cytochrome P450 Enzymes
      Svetlana A. Cherstniakova, Daoqin Bi, Daniel R. Fuller, Jurij Z. Mojsiak, Jerry M. Collins and Louis R. Cantilena
      Drug Metabolism and Disposition September 2001, 29 (9) 1216-1220;

  5. Brimfield, Alan A.

    1. Metabolism of Chlorpyrifos by Human Cytochrome P450 Isoforms and Human, Mouse, and Rat Liver Microsomes
      Jun Tang, Yan Cao, Randy L. Rose, Alan A. Brimfield, Diana Dai, Joyce A. Goldstein and Ernest Hodgson
      Drug Metabolism and Disposition September 2001, 29 (9) 1201-1204;

  6. Bryant, Stewart

    1. Cytochrome P450 Induction in Rat Hepatocytes Assessed by Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction and the RNA Invasive Cleavage Assay
      Michael E. Burczynski, Michael McMillian, James B. Parker, Stewart Bryant, Angelique Leone, Elfrida R. Grant, Jacqueline M. Thorne, Zhong Zhong, Robert A. Zivin and Mark D. Johnson
      Drug Metabolism and Disposition September 2001, 29 (9) 1243-1250;

  7. Burczynski, Michael E.

    1. Cytochrome P450 Induction in Rat Hepatocytes Assessed by Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction and the RNA Invasive Cleavage Assay
      Michael E. Burczynski, Michael McMillian, James B. Parker, Stewart Bryant, Angelique Leone, Elfrida R. Grant, Jacqueline M. Thorne, Zhong Zhong, Robert A. Zivin and Mark D. Johnson
      Drug Metabolism and Disposition September 2001, 29 (9) 1243-1250;

C

  1. Cantilena, Louis R.

    1. Metabolism of Vanoxerine, 1-[2-[bis(4-Fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl) Piperazine, by Human Cytochrome P450 Enzymes
      Svetlana A. Cherstniakova, Daoqin Bi, Daniel R. Fuller, Jurij Z. Mojsiak, Jerry M. Collins and Louis R. Cantilena
      Drug Metabolism and Disposition September 2001, 29 (9) 1216-1220;

  2. Cao, Yan

    1. Metabolism of Chlorpyrifos by Human Cytochrome P450 Isoforms and Human, Mouse, and Rat Liver Microsomes
      Jun Tang, Yan Cao, Randy L. Rose, Alan A. Brimfield, Diana Dai, Joyce A. Goldstein and Ernest Hodgson
      Drug Metabolism and Disposition September 2001, 29 (9) 1201-1204;

  3. Casciano, Christopher N.

    1. In Vitro Characterization of the Inhibition Profile of Loratadine, Desloratadine, and 3-OH-Desloratadine for Five Human Cytochrome P-450 Enzymes
      Mary E. Barecki, Christopher N. Casciano, William W. Johnson and Robert P. Clement
      Drug Metabolism and Disposition September 2001, 29 (9) 1173-1175;

  4. Chauret, Nathalie

    1. The Use of 3-[2-(N,N-Diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a Specific CYP2D6 Probe in Human Liver Microsomes
      Nathalie Chauret, Barry Dobbs, Rebecca L. Lackman, Kevin Bateman, Deborah A. Nicoll-Griffith, David M. Stresser, Joseph M. Ackermann, Stephanie D. Turner, Vaughn P. Miller and Charles L. Crespi
      Drug Metabolism and Disposition September 2001, 29 (9) 1196-1200;

  5. Chen, Sheng Chong

    1. Depentylation of the Rat Esophageal Carcinogen, Methyl-n-pentylnitrosamine, by Microsomes from Various Human and Rat Tissues and by Cytochrome P450 2A3
      Sheng Chong Chen, Lin Zhou, Xinxin Ding and Sidney S. Mirvish
      Drug Metabolism and Disposition September 2001, 29 (9) 1221-1228;

  6. Chen, Ta-Liang

    1. Induction of Cytochromes P450 1A1 and 1B1 by Emodin in Human Lung Adenocarcinoma Cell Line CL5
      Hui-Wu Wang, Ta-Liang Chen, Pan-Chyr Yang and Tzuu-Huei Ueng
      Drug Metabolism and Disposition September 2001, 29 (9) 1229-1235;

  7. Cherstniakova, Svetlana A.

    1. Metabolism of Vanoxerine, 1-[2-[bis(4-Fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl) Piperazine, by Human Cytochrome P450 Enzymes
      Svetlana A. Cherstniakova, Daoqin Bi, Daniel R. Fuller, Jurij Z. Mojsiak, Jerry M. Collins and Louis R. Cantilena
      Drug Metabolism and Disposition September 2001, 29 (9) 1216-1220;

  8. Chiellini, Grazia

    1. Effect of α-Fluorination of Valproic Acid on Valproyl-S-Acyl-CoA Formation in Vivo in Rats
      Mark P. Grillo, Grazia Chiellini, Marco Tonelli and Leslie Z. Benet
      Drug Metabolism and Disposition September 2001, 29 (9) 1210-1215;

  9. Chou, Fang-Chun

    1. Genetic Polymorphism of Cytochrome P450 3A5 in Chinese
      Fang-Chun Chou, Shwu-Jen Tzeng and Jin-ding Huang
      Drug Metabolism and Disposition September 2001, 29 (9) 1205-1209;

  10. Clement, Robert P.

    1. In Vitro Characterization of the Inhibition Profile of Loratadine, Desloratadine, and 3-OH-Desloratadine for Five Human Cytochrome P-450 Enzymes
      Mary E. Barecki, Christopher N. Casciano, William W. Johnson and Robert P. Clement
      Drug Metabolism and Disposition September 2001, 29 (9) 1173-1175;

  11. Collins, Jerry M.

    1. Metabolism of Vanoxerine, 1-[2-[bis(4-Fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl) Piperazine, by Human Cytochrome P450 Enzymes
      Svetlana A. Cherstniakova, Daoqin Bi, Daniel R. Fuller, Jurij Z. Mojsiak, Jerry M. Collins and Louis R. Cantilena
      Drug Metabolism and Disposition September 2001, 29 (9) 1216-1220;

  12. Crespi, Charles L.

    1. The Use of 3-[2-(N,N-Diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a Specific CYP2D6 Probe in Human Liver Microsomes
      Nathalie Chauret, Barry Dobbs, Rebecca L. Lackman, Kevin Bateman, Deborah A. Nicoll-Griffith, David M. Stresser, Joseph M. Ackermann, Stephanie D. Turner, Vaughn P. Miller and Charles L. Crespi
      Drug Metabolism and Disposition September 2001, 29 (9) 1196-1200;

D

  1. Dai, Diana

    1. Metabolism of Chlorpyrifos by Human Cytochrome P450 Isoforms and Human, Mouse, and Rat Liver Microsomes
      Jun Tang, Yan Cao, Randy L. Rose, Alan A. Brimfield, Diana Dai, Joyce A. Goldstein and Ernest Hodgson
      Drug Metabolism and Disposition September 2001, 29 (9) 1201-1204;

  2. Ding, Xinxin

    1. Depentylation of the Rat Esophageal Carcinogen, Methyl-n-pentylnitrosamine, by Microsomes from Various Human and Rat Tissues and by Cytochrome P450 2A3
      Sheng Chong Chen, Lin Zhou, Xinxin Ding and Sidney S. Mirvish
      Drug Metabolism and Disposition September 2001, 29 (9) 1221-1228;

  3. Dobbs, Barry

    1. The Use of 3-[2-(N,N-Diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a Specific CYP2D6 Probe in Human Liver Microsomes
      Nathalie Chauret, Barry Dobbs, Rebecca L. Lackman, Kevin Bateman, Deborah A. Nicoll-Griffith, David M. Stresser, Joseph M. Ackermann, Stephanie D. Turner, Vaughn P. Miller and Charles L. Crespi
      Drug Metabolism and Disposition September 2001, 29 (9) 1196-1200;

F

  1. Fontaine, S. M.

    1. Role of Induction of Specific Hepatic Cytochrome P450 Isoforms in Epoxidation of 4-Vinylcyclohexene
      S. M. Fontaine, P. B. Hoyer, J. R. Halpert and I. G. Sipes
      Drug Metabolism and Disposition September 2001, 29 (9) 1236-1242;

  2. Fuller, Daniel R.

    1. Metabolism of Vanoxerine, 1-[2-[bis(4-Fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl) Piperazine, by Human Cytochrome P450 Enzymes
      Svetlana A. Cherstniakova, Daoqin Bi, Daniel R. Fuller, Jurij Z. Mojsiak, Jerry M. Collins and Louis R. Cantilena
      Drug Metabolism and Disposition September 2001, 29 (9) 1216-1220;

G

  1. Gillam, Elizabeth M. J.

    1. Metabolic Activation of Polycyclic Aromatic Hydrocarbons and Other Procarcinogens by Cytochromes P450 1A1 and P450 1B1 Allelic Variants and Other Human Cytochromes P450 in Salmonella typhimurium NM2009
      Tsutomu Shimada, Yoshimitsu Oda, Elizabeth M. J. Gillam, F. Peter Guengerich and Kiyoshi Inoue
      Drug Metabolism and Disposition September 2001, 29 (9) 1176-1182;

  2. Goldstein, Joyce A.

    1. Metabolism of Chlorpyrifos by Human Cytochrome P450 Isoforms and Human, Mouse, and Rat Liver Microsomes
      Jun Tang, Yan Cao, Randy L. Rose, Alan A. Brimfield, Diana Dai, Joyce A. Goldstein and Ernest Hodgson
      Drug Metabolism and Disposition September 2001, 29 (9) 1201-1204;

  3. Grant, Elfrida R.

    1. Cytochrome P450 Induction in Rat Hepatocytes Assessed by Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction and the RNA Invasive Cleavage Assay
      Michael E. Burczynski, Michael McMillian, James B. Parker, Stewart Bryant, Angelique Leone, Elfrida R. Grant, Jacqueline M. Thorne, Zhong Zhong, Robert A. Zivin and Mark D. Johnson
      Drug Metabolism and Disposition September 2001, 29 (9) 1243-1250;

  4. Grillo, Mark P.

    1. Effect of α-Fluorination of Valproic Acid on Valproyl-S-Acyl-CoA Formation in Vivo in Rats
      Mark P. Grillo, Grazia Chiellini, Marco Tonelli and Leslie Z. Benet
      Drug Metabolism and Disposition September 2001, 29 (9) 1210-1215;

  5. Guengerich, F. Peter

    1. Metabolic Activation of Polycyclic Aromatic Hydrocarbons and Other Procarcinogens by Cytochromes P450 1A1 and P450 1B1 Allelic Variants and Other Human Cytochromes P450 in Salmonella typhimurium NM2009
      Tsutomu Shimada, Yoshimitsu Oda, Elizabeth M. J. Gillam, F. Peter Guengerich and Kiyoshi Inoue
      Drug Metabolism and Disposition September 2001, 29 (9) 1176-1182;

H

  1. Halpert, J. R.

    1. Role of Induction of Specific Hepatic Cytochrome P450 Isoforms in Epoxidation of 4-Vinylcyclohexene
      S. M. Fontaine, P. B. Hoyer, J. R. Halpert and I. G. Sipes
      Drug Metabolism and Disposition September 2001, 29 (9) 1236-1242;

  2. Hodgson, Ernest

    1. Metabolism of Chlorpyrifos by Human Cytochrome P450 Isoforms and Human, Mouse, and Rat Liver Microsomes
      Jun Tang, Yan Cao, Randy L. Rose, Alan A. Brimfield, Diana Dai, Joyce A. Goldstein and Ernest Hodgson
      Drug Metabolism and Disposition September 2001, 29 (9) 1201-1204;

  3. Horie, Toshiharu

    1. Mechanism-Based Inactivation of CYP2C11 by Diclofenac
      Yasuhiro Masubuchi, Atsushi Ose and Toshiharu Horie
      Drug Metabolism and Disposition September 2001, 29 (9) 1190-1195;

  4. Hoyer, P. B.

    1. Role of Induction of Specific Hepatic Cytochrome P450 Isoforms in Epoxidation of 4-Vinylcyclohexene
      S. M. Fontaine, P. B. Hoyer, J. R. Halpert and I. G. Sipes
      Drug Metabolism and Disposition September 2001, 29 (9) 1236-1242;

  5. Huang, Jin-ding

    1. Genetic Polymorphism of Cytochrome P450 3A5 in Chinese
      Fang-Chun Chou, Shwu-Jen Tzeng and Jin-ding Huang
      Drug Metabolism and Disposition September 2001, 29 (9) 1205-1209;

I

  1. Inoue, Kiyoshi

    1. Metabolic Activation of Polycyclic Aromatic Hydrocarbons and Other Procarcinogens by Cytochromes P450 1A1 and P450 1B1 Allelic Variants and Other Human Cytochromes P450 in Salmonella typhimurium NM2009
      Tsutomu Shimada, Yoshimitsu Oda, Elizabeth M. J. Gillam, F. Peter Guengerich and Kiyoshi Inoue
      Drug Metabolism and Disposition September 2001, 29 (9) 1176-1182;

J

  1. Johnson, Mark D.

    1. Cytochrome P450 Induction in Rat Hepatocytes Assessed by Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction and the RNA Invasive Cleavage Assay
      Michael E. Burczynski, Michael McMillian, James B. Parker, Stewart Bryant, Angelique Leone, Elfrida R. Grant, Jacqueline M. Thorne, Zhong Zhong, Robert A. Zivin and Mark D. Johnson
      Drug Metabolism and Disposition September 2001, 29 (9) 1243-1250;

  2. Johnson, William W.

    1. In Vitro Characterization of the Inhibition Profile of Loratadine, Desloratadine, and 3-OH-Desloratadine for Five Human Cytochrome P-450 Enzymes
      Mary E. Barecki, Christopher N. Casciano, William W. Johnson and Robert P. Clement
      Drug Metabolism and Disposition September 2001, 29 (9) 1173-1175;

L

  1. Lackman, Rebecca L.

    1. The Use of 3-[2-(N,N-Diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a Specific CYP2D6 Probe in Human Liver Microsomes
      Nathalie Chauret, Barry Dobbs, Rebecca L. Lackman, Kevin Bateman, Deborah A. Nicoll-Griffith, David M. Stresser, Joseph M. Ackermann, Stephanie D. Turner, Vaughn P. Miller and Charles L. Crespi
      Drug Metabolism and Disposition September 2001, 29 (9) 1196-1200;

  2. Lau, Chyan E.

    1. Simultaneous Pharmacokinetic Modeling of Cocaine and Its Metabolites, Norcocaine and Benzoylecgonine, after Intravenous and Oral Administration in Rats
      Lei Sun and Chyan E. Lau
      Drug Metabolism and Disposition September 2001, 29 (9) 1183-1189;

  3. Leone, Angelique

    1. Cytochrome P450 Induction in Rat Hepatocytes Assessed by Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction and the RNA Invasive Cleavage Assay
      Michael E. Burczynski, Michael McMillian, James B. Parker, Stewart Bryant, Angelique Leone, Elfrida R. Grant, Jacqueline M. Thorne, Zhong Zhong, Robert A. Zivin and Mark D. Johnson
      Drug Metabolism and Disposition September 2001, 29 (9) 1243-1250;

M

  1. Masubuchi, Yasuhiro

    1. Mechanism-Based Inactivation of CYP2C11 by Diclofenac
      Yasuhiro Masubuchi, Atsushi Ose and Toshiharu Horie
      Drug Metabolism and Disposition September 2001, 29 (9) 1190-1195;

  2. McMillian, Michael

    1. Cytochrome P450 Induction in Rat Hepatocytes Assessed by Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction and the RNA Invasive Cleavage Assay
      Michael E. Burczynski, Michael McMillian, James B. Parker, Stewart Bryant, Angelique Leone, Elfrida R. Grant, Jacqueline M. Thorne, Zhong Zhong, Robert A. Zivin and Mark D. Johnson
      Drug Metabolism and Disposition September 2001, 29 (9) 1243-1250;

  3. Miller, Vaughn P.

    1. The Use of 3-[2-(N,N-Diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a Specific CYP2D6 Probe in Human Liver Microsomes
      Nathalie Chauret, Barry Dobbs, Rebecca L. Lackman, Kevin Bateman, Deborah A. Nicoll-Griffith, David M. Stresser, Joseph M. Ackermann, Stephanie D. Turner, Vaughn P. Miller and Charles L. Crespi
      Drug Metabolism and Disposition September 2001, 29 (9) 1196-1200;

  4. Mirvish, Sidney S.

    1. Depentylation of the Rat Esophageal Carcinogen, Methyl-n-pentylnitrosamine, by Microsomes from Various Human and Rat Tissues and by Cytochrome P450 2A3
      Sheng Chong Chen, Lin Zhou, Xinxin Ding and Sidney S. Mirvish
      Drug Metabolism and Disposition September 2001, 29 (9) 1221-1228;

  5. Mojsiak, Jurij Z.

    1. Metabolism of Vanoxerine, 1-[2-[bis(4-Fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl) Piperazine, by Human Cytochrome P450 Enzymes
      Svetlana A. Cherstniakova, Daoqin Bi, Daniel R. Fuller, Jurij Z. Mojsiak, Jerry M. Collins and Louis R. Cantilena
      Drug Metabolism and Disposition September 2001, 29 (9) 1216-1220;

N

  1. Nicoll-Griffith, Deborah A.

    1. The Use of 3-[2-(N,N-Diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a Specific CYP2D6 Probe in Human Liver Microsomes
      Nathalie Chauret, Barry Dobbs, Rebecca L. Lackman, Kevin Bateman, Deborah A. Nicoll-Griffith, David M. Stresser, Joseph M. Ackermann, Stephanie D. Turner, Vaughn P. Miller and Charles L. Crespi
      Drug Metabolism and Disposition September 2001, 29 (9) 1196-1200;

O

  1. Oda, Yoshimitsu

    1. Metabolic Activation of Polycyclic Aromatic Hydrocarbons and Other Procarcinogens by Cytochromes P450 1A1 and P450 1B1 Allelic Variants and Other Human Cytochromes P450 in Salmonella typhimurium NM2009
      Tsutomu Shimada, Yoshimitsu Oda, Elizabeth M. J. Gillam, F. Peter Guengerich and Kiyoshi Inoue
      Drug Metabolism and Disposition September 2001, 29 (9) 1176-1182;

  2. Ose, Atsushi

    1. Mechanism-Based Inactivation of CYP2C11 by Diclofenac
      Yasuhiro Masubuchi, Atsushi Ose and Toshiharu Horie
      Drug Metabolism and Disposition September 2001, 29 (9) 1190-1195;

P

  1. Parker, James B.

    1. Cytochrome P450 Induction in Rat Hepatocytes Assessed by Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction and the RNA Invasive Cleavage Assay
      Michael E. Burczynski, Michael McMillian, James B. Parker, Stewart Bryant, Angelique Leone, Elfrida R. Grant, Jacqueline M. Thorne, Zhong Zhong, Robert A. Zivin and Mark D. Johnson
      Drug Metabolism and Disposition September 2001, 29 (9) 1243-1250;

R

  1. Rose, Randy L.

    1. Metabolism of Chlorpyrifos by Human Cytochrome P450 Isoforms and Human, Mouse, and Rat Liver Microsomes
      Jun Tang, Yan Cao, Randy L. Rose, Alan A. Brimfield, Diana Dai, Joyce A. Goldstein and Ernest Hodgson
      Drug Metabolism and Disposition September 2001, 29 (9) 1201-1204;

S

  1. Shimada, Tsutomu

    1. Metabolic Activation of Polycyclic Aromatic Hydrocarbons and Other Procarcinogens by Cytochromes P450 1A1 and P450 1B1 Allelic Variants and Other Human Cytochromes P450 in Salmonella typhimurium NM2009
      Tsutomu Shimada, Yoshimitsu Oda, Elizabeth M. J. Gillam, F. Peter Guengerich and Kiyoshi Inoue
      Drug Metabolism and Disposition September 2001, 29 (9) 1176-1182;

  2. Sipes, I. G.

    1. Role of Induction of Specific Hepatic Cytochrome P450 Isoforms in Epoxidation of 4-Vinylcyclohexene
      S. M. Fontaine, P. B. Hoyer, J. R. Halpert and I. G. Sipes
      Drug Metabolism and Disposition September 2001, 29 (9) 1236-1242;

  3. Stresser, David M.

    1. The Use of 3-[2-(N,N-Diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a Specific CYP2D6 Probe in Human Liver Microsomes
      Nathalie Chauret, Barry Dobbs, Rebecca L. Lackman, Kevin Bateman, Deborah A. Nicoll-Griffith, David M. Stresser, Joseph M. Ackermann, Stephanie D. Turner, Vaughn P. Miller and Charles L. Crespi
      Drug Metabolism and Disposition September 2001, 29 (9) 1196-1200;

  4. Sun, Lei

    1. Simultaneous Pharmacokinetic Modeling of Cocaine and Its Metabolites, Norcocaine and Benzoylecgonine, after Intravenous and Oral Administration in Rats
      Lei Sun and Chyan E. Lau
      Drug Metabolism and Disposition September 2001, 29 (9) 1183-1189;

T

  1. Tang, Jun

    1. Metabolism of Chlorpyrifos by Human Cytochrome P450 Isoforms and Human, Mouse, and Rat Liver Microsomes
      Jun Tang, Yan Cao, Randy L. Rose, Alan A. Brimfield, Diana Dai, Joyce A. Goldstein and Ernest Hodgson
      Drug Metabolism and Disposition September 2001, 29 (9) 1201-1204;

  2. Thorne, Jacqueline M.

    1. Cytochrome P450 Induction in Rat Hepatocytes Assessed by Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction and the RNA Invasive Cleavage Assay
      Michael E. Burczynski, Michael McMillian, James B. Parker, Stewart Bryant, Angelique Leone, Elfrida R. Grant, Jacqueline M. Thorne, Zhong Zhong, Robert A. Zivin and Mark D. Johnson
      Drug Metabolism and Disposition September 2001, 29 (9) 1243-1250;

  3. Tonelli, Marco

    1. Effect of α-Fluorination of Valproic Acid on Valproyl-S-Acyl-CoA Formation in Vivo in Rats
      Mark P. Grillo, Grazia Chiellini, Marco Tonelli and Leslie Z. Benet
      Drug Metabolism and Disposition September 2001, 29 (9) 1210-1215;

  4. Turner, Stephanie D.

    1. The Use of 3-[2-(N,N-Diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a Specific CYP2D6 Probe in Human Liver Microsomes
      Nathalie Chauret, Barry Dobbs, Rebecca L. Lackman, Kevin Bateman, Deborah A. Nicoll-Griffith, David M. Stresser, Joseph M. Ackermann, Stephanie D. Turner, Vaughn P. Miller and Charles L. Crespi
      Drug Metabolism and Disposition September 2001, 29 (9) 1196-1200;

  5. Tzeng, Shwu-Jen

    1. Genetic Polymorphism of Cytochrome P450 3A5 in Chinese
      Fang-Chun Chou, Shwu-Jen Tzeng and Jin-ding Huang
      Drug Metabolism and Disposition September 2001, 29 (9) 1205-1209;

U

  1. Ueng, Tzuu-Huei

    1. Induction of Cytochromes P450 1A1 and 1B1 by Emodin in Human Lung Adenocarcinoma Cell Line CL5
      Hui-Wu Wang, Ta-Liang Chen, Pan-Chyr Yang and Tzuu-Huei Ueng
      Drug Metabolism and Disposition September 2001, 29 (9) 1229-1235;

W

  1. Wang, Hui-Wu

    1. Induction of Cytochromes P450 1A1 and 1B1 by Emodin in Human Lung Adenocarcinoma Cell Line CL5
      Hui-Wu Wang, Ta-Liang Chen, Pan-Chyr Yang and Tzuu-Huei Ueng
      Drug Metabolism and Disposition September 2001, 29 (9) 1229-1235;

Y

  1. Yang, Pan-Chyr

    1. Induction of Cytochromes P450 1A1 and 1B1 by Emodin in Human Lung Adenocarcinoma Cell Line CL5
      Hui-Wu Wang, Ta-Liang Chen, Pan-Chyr Yang and Tzuu-Huei Ueng
      Drug Metabolism and Disposition September 2001, 29 (9) 1229-1235;

Z

  1. Zhong, Zhong

    1. Cytochrome P450 Induction in Rat Hepatocytes Assessed by Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction and the RNA Invasive Cleavage Assay
      Michael E. Burczynski, Michael McMillian, James B. Parker, Stewart Bryant, Angelique Leone, Elfrida R. Grant, Jacqueline M. Thorne, Zhong Zhong, Robert A. Zivin and Mark D. Johnson
      Drug Metabolism and Disposition September 2001, 29 (9) 1243-1250;

  2. Zhou, Lin

    1. Depentylation of the Rat Esophageal Carcinogen, Methyl-n-pentylnitrosamine, by Microsomes from Various Human and Rat Tissues and by Cytochrome P450 2A3
      Sheng Chong Chen, Lin Zhou, Xinxin Ding and Sidney S. Mirvish
      Drug Metabolism and Disposition September 2001, 29 (9) 1221-1228;

  3. Zivin, Robert A.

    1. Cytochrome P450 Induction in Rat Hepatocytes Assessed by Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction and the RNA Invasive Cleavage Assay
      Michael E. Burczynski, Michael McMillian, James B. Parker, Stewart Bryant, Angelique Leone, Elfrida R. Grant, Jacqueline M. Thorne, Zhong Zhong, Robert A. Zivin and Mark D. Johnson
      Drug Metabolism and Disposition September 2001, 29 (9) 1243-1250;
Back to top

In this issue